annual FCF:
-$207.34M-$70.03M(-51.01%)Summary
- As of today (July 1, 2025), KYMR annual free cash flow is -$207.34 million, with the most recent change of -$70.03 million (-51.01%) on December 31, 2024.
- During the last 3 years, KYMR annual FCF has fallen by -$76.80 million (-58.83%).
- KYMR annual FCF is now -362.34% below its all-time high of $79.03 million, reached on December 31, 2020.
Performance
KYMR Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$79.62M-$16.90M(-26.94%)Summary
- As of today (July 1, 2025), KYMR quarterly free cash flow is -$79.62 million, with the most recent change of -$16.90 million (-26.94%) on March 31, 2025.
- Over the past year, KYMR quarterly FCF has dropped by -$32.62 million (-69.42%).
- KYMR quarterly FCF is now -161.60% below its all-time high of $129.26 million, reached on September 30, 2020.
Performance
KYMR quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$239.96M-$32.62M(-15.73%)Summary
- As of today (July 1, 2025), KYMR TTM free cash flow is -$239.96 million, with the most recent change of -$32.62 million (-15.73%) on March 31, 2025.
- Over the past year, KYMR TTM FCF has dropped by -$103.64 million (-76.03%).
- KYMR TTM FCF is now -338.68% below its all-time high of $100.54 million, reached on September 30, 2020.
Performance
KYMR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
KYMR Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.0% | -69.4% | -76.0% |
| 3 y3 years | -58.8% | -95.3% | -61.8% |
| 5 y5 years | -1293.5% | -491.9% | -735.5% |
KYMR Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.8% | at low | -2123.9% | at low | -76.0% | at low |
| 5 y | 5-year | -362.3% | at low | -161.6% | at low | -338.7% | at low |
| alltime | all time | -362.3% | at low | -161.6% | at low | -338.7% | at low |
KYMR Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$79.62M(+26.9%) | -$239.96M(+15.7%) |
| Dec 2024 | -$207.34M(+51.0%) | -$62.72M(+25.4%) | -$207.34M(+39.9%) |
| Sep 2024 | - | -$50.00M(+5.0%) | -$148.20M(+7.5%) |
| Jun 2024 | - | -$47.63M(+1.3%) | -$137.92M(+1.2%) |
| Mar 2024 | - | -$46.99M(+1212.7%) | -$136.32M(-0.7%) |
| Dec 2023 | -$137.31M(-11.9%) | -$3.58M(-91.0%) | -$137.31M(-20.9%) |
| Sep 2023 | - | -$39.73M(-13.7%) | -$173.63M(+2.5%) |
| Jun 2023 | - | -$46.02M(-4.1%) | -$169.43M(+3.9%) |
| Mar 2023 | - | -$47.98M(+20.2%) | -$163.12M(+4.6%) |
| Dec 2022 | -$155.92M | -$39.91M(+12.4%) | -$155.92M(+0.7%) |
| Sep 2022 | - | -$35.52M(-10.6%) | -$154.87M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$39.72M(-2.6%) | -$156.92M(+5.8%) |
| Mar 2022 | - | -$40.78M(+5.0%) | -$148.33M(+13.6%) |
| Dec 2021 | -$130.54M(-265.2%) | -$38.85M(+3.4%) | -$130.54M(+15.3%) |
| Sep 2021 | - | -$37.57M(+20.6%) | -$113.19M(-311.1%) |
| Jun 2021 | - | -$31.14M(+35.5%) | $53.63M(-22.8%) |
| Mar 2021 | - | -$22.99M(+6.9%) | $69.50M(-12.1%) |
| Dec 2020 | $79.03M(+354.9%) | -$21.50M(-116.6%) | $79.03M(-21.4%) |
| Sep 2020 | - | $129.26M(-946.6%) | $100.54M(-450.1%) |
| Jun 2020 | - | -$15.27M(+13.5%) | -$28.72M(+113.5%) |
| Mar 2020 | - | -$13.45M | -$13.45M |
| Dec 2019 | $17.37M(-190.4%) | - | - |
| Dec 2018 | -$19.22M | - | - |
FAQ
- What is Kymera Therapeutics annual free cash flow?
- What is the all time high annual FCF for Kymera Therapeutics?
- What is Kymera Therapeutics annual FCF year-on-year change?
- What is Kymera Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly FCF year-on-year change?
- What is Kymera Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Kymera Therapeutics?
- What is Kymera Therapeutics TTM FCF year-on-year change?
What is Kymera Therapeutics annual free cash flow?
The current annual FCF of KYMR is -$207.34M
What is the all time high annual FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high annual free cash flow is $79.03M
What is Kymera Therapeutics annual FCF year-on-year change?
Over the past year, KYMR annual free cash flow has changed by -$70.03M (-51.01%)
What is Kymera Therapeutics quarterly free cash flow?
The current quarterly FCF of KYMR is -$79.62M
What is the all time high quarterly FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly free cash flow is $129.26M
What is Kymera Therapeutics quarterly FCF year-on-year change?
Over the past year, KYMR quarterly free cash flow has changed by -$32.62M (-69.42%)
What is Kymera Therapeutics TTM free cash flow?
The current TTM FCF of KYMR is -$239.96M
What is the all time high TTM FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM free cash flow is $100.54M
What is Kymera Therapeutics TTM FCF year-on-year change?
Over the past year, KYMR TTM free cash flow has changed by -$103.64M (-76.03%)